PROLOR Biotech, Inc. Shareholder Alert: Briscoe Law Firm and Powers Taylor,
LLP Investigate Acquisition Agreement
DALLAS -- April 26, 2013
Former United States Securities and Exchange Commission attorney Willie
Briscoe and the securities litigation firm of Powers Taylor, LLP are
investigating the sale of PROLOR Biotech, Inc. (“PROLOR” or Company) (NYSE:
PBTH) to OPKO Health, Inc. Under the terms of the proposed deal, PROLOR
shareholders will only receive 0.9951 shares of OPKO stock for each PROLOR
stock they own. The transaction values PROLOR stock at approximately $7.025
per share. Yet, analysts have recently set PROLOR’s true value as high as
$10.00 to $12.00 per share.
If you are an affected investor, and you want to learn more about the lawsuit
or join the action, please contact Willie Briscoe at The Briscoe Law Firm,
PLLC, (214) 239-4568, via email at WBriscoe@TheBriscoeLawFirm.com or Zach
Groover at Powers Taylor, LLP, toll free (877) 728-9607, via e-mail at
firstname.lastname@example.org. There is no cost or fee to you.
The PROLOR sale investigation centers on whether the Company’s shareholders
are receiving adequate compensation for their shares in the proposed
acquisition, whether the transaction undervalues PROLOR’s stock, and whether
PROLOR’s board attempted to obtain the highest share price for all
shareholders prior to agreeing to the deal.
The Briscoe Law Firm, PLLC is a full service business litigation and
shareholder rights advocacy firm with more than 20 years of experience in
complex litigation and transactional matters.
Powers Taylor, LLP is a boutique litigation law firm that handles a variety of
complex business litigation matters, including claims of investor and
stockholder fraud, shareholder oppression, shareholder derivative suits, and
security class actions.
The Briscoe Law Firm, PLLC
Willie Briscoe, 214-239-4568
Powers Taylor, LLP
Zach Groover, 877-728-9607
Press spacebar to pause and continue. Press esc to stop.